Navigate With Confidence
Bionavigen is a biopharmaceutical navigation company specializing in consulting for the discovery, preclinical development, translational, and regulatory sciences as well as early development of new drugs through smart acquisition.
WHY BIONAVIGEN?
Bionavigen offers real world drug development experience-based consulting services for biologics including:
Antibodies
Peptides
Recombinant Proteins
Bispecifics
Antibody Drug Conjugates (ADC)
Oncolytic Virus (gene editing and gene delivery)
Viral
Cell
Gene Therapy
Small Molecule Pharmaceuticals
Therapeutic Peptides
Medical Devices
Bionavigen Advantage:
- A team of virtual full drug developers (preclinical, clinical and regulatory experts)
- Actively engaged in acquisition of clinical stage biologics and small molecule drugs from pharmaceutical companies supported by funds from VC investment firms
- Support from early VC funding to early proof-of-concept clinical trials
Bionavigen Drug Hunting Services:
- Navigation of the current and future pipeline of the top ten biopharmaceutical companies
- Smart due diligence of potential out-licensing candidates using the latest scientific knowledge and soft intelligence
- Special emphasis on promising drug candidates in new disease indications or through new innovative combinations
- Investor backed drug acquisition and development through proof-of-concept
30
Years of Experience
10
Marketed Biopharmaceuticals
100+
INDs
15
BLAs-NDAs
Ready to Navigate Your Drug Development Journey?
With 30 years of experience and a proven track record, Bionavigen is your trusted partner from discovery to market.
SCHEDULE A CALL